APA (7th ed.) Citation

Sundar, S., Mehta, H., Suresh, A. V., Singh, S. P., Madhukar, R., & Murray, H. W. (2004). Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional versus Lipid Formulations. Clinical infectious diseases, 38(3), 377-383. https://doi.org/10.1086/380971

Chicago Style (17th ed.) Citation

Sundar, Shyam, Himanshu Mehta, A. V. Suresh, Shri P. Singh, Rai Madhukar, and Henry W. Murray. "Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional Versus Lipid Formulations." Clinical Infectious Diseases 38, no. 3 (2004): 377-383. https://doi.org/10.1086/380971.

MLA (9th ed.) Citation

Sundar, Shyam, et al. "Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional Versus Lipid Formulations." Clinical Infectious Diseases, vol. 38, no. 3, 2004, pp. 377-383, https://doi.org/10.1086/380971.